Search filters

List of works by Javier Castillo-Olivares

A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model.

scientific article

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model

scientific article published on 08 October 2018

African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination

scientific article published on 02 October 2020

Analysis of ORFs 2b, 3, 4, and partial ORF5 of sequential isolates of equine arteritis virus shows genetic variation following experimental infection of horses.

scientific article published on 29 November 2007

Antibody response in horses following experimental infection with West Nile Virus lineages 1 and 2.

scientific article published on 12 January 2011

Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.

scientific article published on 30 January 2015

Assessment of reproducibility of a VP7 Blocking ELISA diagnostic test for African horse sickness

scientific article published on 02 August 2018

Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses

scientific article published on 18 July 2022

Detection of equine arteritis virus (EAV)-specific cytotoxic CD8+ T lymphocyte precursors from EAV-infected ponies

scientific article published in October 2003

Development and evaluation of ELISA procedures to detect antibodies against the major envelope protein (G(L)) of equine arteritis virus

scientific article published in November 2000

Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Assay for the Rapid Detection of African Horse Sickness Virus.

scientific article published on 2 August 2016

Evaluation of a prototype sub-unit vaccine against equine arteritis virus comprising the entire ectodomain of the virus large envelope glycoprotein (G(L)): induction of virus-neutralizing antibody and assessment of protection in ponies

scientific article published in October 2001

Evidence that use of an inactivated equine herpesvirus vaccine induces serum cytotoxicity affecting the equine arteritis virus neutralisation test

scientific article published on September 2004

Expression and secretion of Bluetongue virus serotype 8 (BTV-8)VP2 outer capsid protein by mammalian cells.

scientific article published on 10 August 2010

Identification of CD8 T cell epitopes in VP2 and NS1 proteins of African horse sickness virus in IFNAR(-/-) mice.

scientific article published on 10 August 2015

Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).

scientific article

Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.

scientific article

Real time RT-PCR assays for detection and typing of African horse sickness virus

scientific article

Recombinant vaccines against bluetongue virus

scientific article

Testing for equine arteritis virus

scientific article published on 01 April 2003

Testing for equine arteritis virus.

scientific article published in June 2003

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.

scientific article published on 17 April 2018

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge

scientific article

Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation

scientific article published on 12 December 2013

Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination

scientific article published on 21 April 2017

West Nile virus infection of horses

scientific article published in July 2004

Paulina is supported by:

About Paulina

Help